[Hub]/) : Traits : Impedance of arm (left) :

chr10:64,195,778-65,911,294

Best TWAS P=2.39e-17 · Best GWAS P=8.58e-17 conditioned to 0.0794

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Brain Cortex NRBF2 0.30 0.26 enet 24 0.21 1.4e-06 -7.6 -7.5 5.6e-14 -0.95 0.02 0.98 FALSE
2 GTEx Brain Frontal Cortex BA9 NRBF2 0.25 0.17 lasso 6 0.16 6.1e-05 8.3 -8.1 4.9e-16 -0.98 0.01 0.98 FALSE
3 GTEx Cells Transformed fibroblasts JMJD1C 0.09 0.01 enet 18 0.07 8.6e-06 -6.7 -7.6 4.1e-14 -0.62 0.12 0.71 FALSE
4 GTEx Esophagus Mucosa NRBF2 0.14 0.11 lasso 10 0.11 6.4e-08 8.0 -8.1 6.0e-16 -0.95 0.01 0.99 FALSE
5 GTEx Nerve Tibial NRBF2 0.08 0.09 enet 11 0.06 5.0e-05 8.0 -7.8 4.0e-15 -0.91 0.01 0.99 FALSE
6 GTEx Stomach NRBF2 0.09 0.04 lasso 6 0.03 1.6e-02 -3.3 -5.7 1.1e-08 -0.73 0.08 0.42 FALSE
7 GTEx Testis NRBF2 0.14 0.08 lasso 12 0.09 6.7e-05 8.0 -7.6 2.5e-14 -0.96 0.02 0.98 FALSE
8 GTEx Testis JMJD1C-AS1 0.22 0.08 enet 23 0.10 3.7e-05 -6.3 -6.5 1.0e-10 -0.41 0.67 0.04 FALSE
9 GTEx Thyroid NRBF2 0.11 0.05 lasso 3 0.07 2.5e-06 -4.8 -7.0 2.8e-12 -0.72 0.03 0.97 FALSE
10 ROSMAP Brain Pre-frontal Cortex NRBF2 0.34 0.46 lasso 5 0.46 3.1e-66 8.3 -8.1 6.5e-16 -0.99 0.00 1.00 FALSE
11 The Cancer Genome Atlas Bladder Urothelial Carcinoma NRBF2 0.07 0.04 blup 42 0.02 7.3e-03 8.2 -6.0 2.0e-09 -0.84 0.00 0.98 FALSE
12 The Cancer Genome Atlas Breast Invasive Carcinoma NRBF2 0.05 0.06 lasso 2 0.06 5.5e-12 8.3 -8.2 2.3e-16 -1.00 0.00 1.00 FALSE
13 The Cancer Genome Atlas Colon Adenocarcinoma NRBF2 0.13 0.10 enet 11 0.09 4.9e-06 8.3 -7.5 5.5e-14 -0.85 0.00 1.00 FALSE
14 The Cancer Genome Atlas Glioblastoma Multiforme JMJD1C 0.11 0.02 blup 87 0.05 1.4e-02 8.2 -8.0 1.0e-15 -0.87 0.01 0.74 FALSE
15 The Cancer Genome Atlas Glioblastoma Multiforme NRBF2 0.17 0.09 enet 10 0.13 1.1e-04 8.3 -8.2 3.6e-16 -0.88 0.00 0.96 FALSE
16 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma NRBF2 0.04 0.04 enet 5 0.03 1.3e-04 8.2 -7.6 3.5e-14 -0.97 0.00 0.99 FALSE
17 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma NRBF2 0.10 0.06 lasso 7 0.08 3.5e-09 -3.8 -6.5 9.6e-11 -0.88 0.01 0.99 FALSE
18 The Cancer Genome Atlas Brain Lower Grade Glioma NRBF2 0.08 0.08 enet 6 0.08 4.3e-09 8.3 -7.6 2.6e-14 -0.98 0.00 1.00 FALSE
19 The Cancer Genome Atlas Brain Lower Grade Glioma REEP3 0.04 0.04 blup 59 0.05 1.8e-06 -3.8 5.7 1.5e-08 0.80 0.03 0.97 FALSE
20 The Cancer Genome Atlas Lung Adenocarcinoma NRBF2 0.09 0.06 enet 8 0.07 2.7e-08 8.2 -6.8 1.3e-11 -0.94 0.00 1.00 FALSE
21 The Cancer Genome Atlas Pancreatic Adenocarcinoma LOC84989 0.10 0.05 blup 19 0.04 7.7e-03 -6.2 -7.8 5.0e-15 -0.69 0.01 0.36 FALSE
22 The Cancer Genome Atlas Pancreatic Adenocarcinoma NRBF2 0.18 0.13 enet 11 0.08 2.5e-04 8.2 -7.5 4.6e-14 -0.89 0.00 0.99 FALSE
23 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma NRBF2 0.08 0.02 blup 40 0.04 8.6e-03 8.3 -8.5 2.4e-17 -0.89 0.00 0.90 TRUE
24 The Cancer Genome Atlas Prostate Adenocarcinoma JMJD1C 0.04 0.01 blup 88 0.01 9.7e-03 8.2 -6.1 1.1e-09 -0.87 0.01 0.91 FALSE
25 The Cancer Genome Atlas Prostate Adenocarcinoma NRBF2 0.08 0.09 lasso 6 0.08 9.7e-09 8.2 -7.8 8.1e-15 -0.98 0.00 1.00 FALSE
26 The Cancer Genome Atlas Thyroid Carcinoma NRBF2 0.14 0.10 enet 16 0.09 8.1e-09 8.2 -7.6 3.4e-14 -0.91 0.00 1.00 FALSE